Whole Body Cooling Using Phase Changing Material
Phase II Randomized Control Trial of Whole Body Cooling in Neonatal Encephalopathy Using Phase Changing Material
1 other identifier
interventional
35
1 country
1
Brief Summary
A prospective randomized control trial to examine safety and effectiveness of whole body cooling to a rectal temperature of 33.5 C using phase changing material in neonatal encephalopathy. Effectiveness will be defined by examining the stability of rectal temperature during cooling. Monitoring of vital signs, infection screen, blood counts, coagulation screen, liver and renal function tests, cranial US and MR imaging will be performed on recruited infants to evaluate safety of cooling. EEG will be performed on day 4 and hearing evaluation at discharge. Neurodevelopmental evaluation will be performed at 1 year of age.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_1
Started Jul 2009
Typical duration for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2009
CompletedFirst Submitted
Initial submission to the registry
June 2, 2010
CompletedFirst Posted
Study publicly available on registry
June 7, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2011
CompletedJune 7, 2010
June 1, 2010
1.5 years
June 2, 2010
June 3, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Stability of cooling
Percentage of time for which rectal temperature is maintained between 33 to 34 C during the 72 hours of therapeutic hypothermia
72 hours
Secondary Outcomes (5)
Brain tissue injury on MR imaging
7 to 10 days
Adverse neurodevelopment
12 months
Mortality
4 weeks
EEG abnormality
4 days
Sepsis
1 week
Study Arms (2)
Standard care
NO INTERVENTIONCooling
EXPERIMENTALReduction of rectal temperature to 33.5 C for 72 hours
Interventions
Reduction of rectal temperature to 33.5 C
Eligibility Criteria
You may qualify if:
- Apgar score of \<5 at 5 minutes or continued resuscitation at 5 minutes
- Neonatal encephalopathy
You may not qualify if:
- Imminent death
- Major congenital malformations
- Gestation \<36 weeks
- Birthweight less than 1.8 kg
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Robertson, Nicola, M.D.lead
- Thayyil, Sudhincollaborator
Study Sites (1)
Calicut Medical College
Calicut, India
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Balraj Guhan, MD
Calicut Medical College
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDIV
Study Record Dates
First Submitted
June 2, 2010
First Posted
June 7, 2010
Study Start
July 1, 2009
Primary Completion
January 1, 2011
Study Completion
August 1, 2011
Last Updated
June 7, 2010
Record last verified: 2010-06